{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:17:30Z","timestamp":1794953850059,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116890","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:01:51Z","timestamp":1784646111000},"page":"116890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing venous thromboembolism risk prediction after immunotherapy for lung cancer"],"prefix":"10.1016","volume":"29","author":[{"family":"Shengyuan Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-5332","authenticated-orcid":false,"given":"Xianghuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116890_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and Venous Thromboembolic Disease: A Review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.116890_bib2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116890_bib3","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/cncr.25941","article-title":"Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center","volume":"117","author":"Shinagare","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib4","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update","volume":"41","author":"Key","year":"2023","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.isci.2026.116890_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.116890_bib6","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0049-3848(20)30402-3","article-title":"Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis","volume":"191","author":"Lyman","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.isci.2026.116890_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s10637-019-00881-6","article-title":"Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors","volume":"38","author":"Ando","year":"2020","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.isci.2026.116890_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC. CardioOncol."},{"key":"10.1016\/j.isci.2026.116890_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2021.09.010","article-title":"Immune checkpoint inhibitors for cancer and venous thromboembolic events","volume":"158","author":"Gong","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib10","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood.2020007878","article-title":"Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy","volume":"137","author":"Moik","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116890_bib11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jth.15272","article-title":"Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Icht","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.isci.2026.116890_bib12","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/jth.15883","article-title":"The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study","volume":"20","author":"Overvad","year":"2022","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.isci.2026.116890_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-022-02649-x","article-title":"Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors","volume":"54","author":"Alma","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.isci.2026.116890_bib14","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/onco.13596","article-title":"Update on Guidelines for the Management of Cancer-Associated Thrombosis","volume":"26","author":"Streiff","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.116890_bib15","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/jth.15503","article-title":"Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer","volume":"19","author":"Guman","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.isci.2026.116890_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0010","article-title":"Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer","volume":"6","author":"Cella","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.116890_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"COMPASS\u2013CAT Working Group. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.116890_bib18","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.isci.2026.116890_bib19","first-page":"5417","article-title":"Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Support","volume":"29","author":"Guven","year":"2021","journal-title":"Care Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/bjc.2014.3","article-title":"Thrombosis in ovarian cancer: a case control study","volume":"110","author":"Metcalf","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.29076","article-title":"Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio","volume":"136","author":"Ferroni","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib22","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.2017.48","article-title":"Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index","volume":"116","author":"Carmona-Bayonas","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.116890_bib23","author":"Bauer"},{"key":"10.1016\/j.isci.2026.116890_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular Risk Factors Associated With Venous Thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.isci.2026.116890_bib25","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/eurheartj\/ehr223","article-title":"Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden","volume":"32","author":"Z\u00f6ller","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2026.116890_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2010.01.057","article-title":"Risk factors for venous thromboembolism","volume":"56","author":"Goldhaber","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2026.116890_bib27","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116890_bib28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration","volume":"130","author":"Simes","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.116890_bib29","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.22.00255","article-title":"A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts","volume":"41","author":"Mu\u00f1oz","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116890_bib30","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J. Thromb. Haemostasis."},{"key":"10.1016\/j.isci.2026.116890_bib31","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","article-title":"External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: The COMPASS-CAT venous thromboembolism risk assessment model","volume":"25","author":"Spyropoulos","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.116890_bib32","article-title":"Consistent individualized feature attribution for tree ensembles","author":"Lundberg","year":"2018","journal-title":"arXiv"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:52:40Z","timestamp":1794952360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226022686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226022686"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116890","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing venous thromboembolism risk prediction after immunotherapy for lung cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116890"}}